The generics company Sandoz acquired U.S. pharmaceutical company Oriel Therapeutics.
develops previously privately held U.S. companies generic drugs Asthma and chronic obstructive pulmonary disease (COPD ), such as Sandoz announced on Monday.
replaced with the acquisition of the Novartis subsidiary rights to a portfolio of different generic product candidates and technologies. Further details of the transaction are not known. Oriel is to be integrated as a separate unit in the company of wooden churches.
0 comments:
Post a Comment